"Depuis 1969, l’hôpital pneumologique et cardiovasculaire Louis Pradel concentre des expertises de pointe dans de nombreuses spécialités : cardiologie, chirurgie cardiovasculaire et thoracique, cardio-pédiatrie médico-chirurgicale, endocrinologie, pneumologie, anesthésie-réanimation et soins critiques."

During the past decade, CHU de Lyon - Hopital Louis Pradel conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Lyon - Hopital Louis Pradel" #1 sponsor was "Hospices Civils de Lyon" with 2 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Horizon Therapeutics USA, Inc." with 1 trials sponsored and "Kartos Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Lyon - Hopital Louis Pradel" #1 collaborator was "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Lyon - Hopital Louis Pradel" are "Cancer" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials), "Lung Cancer" (1 trials), "Small Cell Lung Cancer Extensive Stage" (1 trials) and "Small Cell Lung Cancer Recurrent" (1 trials). Many other conditions were trialed in "CHU de Lyon - Hopital Louis Pradel" in a lesser frequency.

Most popular intervention types in "CHU de Lyon - Hopital Louis Pradel" are "Drug" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Estimation of the incidence of the irAE" (1 trials), "GLPG1205" (1 trials), "KRT-232" (1 trials) and "Nivolumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Lyon - Hopital Louis Pradel" are 6 trials for "All" genders.

Currently, there are NaN active trials in "CHU de Lyon - Hopital Louis Pradel". 1 are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHU de Lyon - Hopital Louis Pradel, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Lyon - Hopital Louis Pradel, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".